Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

MedCath Moves Toward Dissolution

A proxy statement to be filed with the U.S. Securities and Exchange Commission will request stockholder approval to authorize the MedCath board to dissolve the company, sell its remaining assets without further stockholder approval, and distribute available net proceeds to stockholders, the company says.

Please enter your comment below:
Please enter the text below: